Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Petra Anheuser

Showing results (31-40 of 37) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 37 results.
Urologia Internationalis|March 19, 2016
MicroRNA miR-371a-3p - A Novel Serum Biomarker of Testicular Germ Cell Tumors: Evidence for Specificity from Measurements in Testicular Vein Blood and in Neoplastic Hydrocele FluidKlaus-Peter Dieckmann, Meike Spiekermann, Thomas Balks, et al.
Journal of Cancer Research and Clinical Oncology|April 27, 2016
Testicular seminoma clinical stage 1: treatment outcome on a routine care levelKlaus-Peter Dieckmann, Inken Dralle-Filiz, Cord Matthies, et al.
BMC Urology|April 19, 2015
Testicular prostheses in patients with testicular cancer - acceptance rate and patient satisfactionKlaus-Peter Dieckmann, Petra Anheuser, Stefan Schmidt, et al.
Urologia Internationalis|April 20, 2016
Seminoma Clinical Stage 1 - Patterns of Care in GermanyKlaus-Peter Dieckmann, Inken Dralle-Filiz, Julia Heinzelbecker, et al.
Antibiotics (Basel, Switzerland)|July 29, 2023
Do or Don't: Results of a Multinational Survey on Antibiotic Prophylaxis in UrodynamicsFabian P Stangl, Laila Schneidewind, Florian M Wagenlehner, et al.
Central European Journal of Urology|November 3, 2018
Desperate need for better management of Fournier's gangreneJennifer Kranz, Daniel Schlager, Petra Anheuser, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 16, 2019
Serum Levels of MicroRNA-371a-3p (M371 Test) as a New Biomarker of Testicular Germ Cell Tumors: Results of a Prospective Multicentric StudyKlaus-Peter Dieckmann, Arlo Radtke, Lajos Geczi, et al.
Pageof 4

Showing results (31-40 of 37) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 37 results.
Urologia Internationalis|March 19, 2016
MicroRNA miR-371a-3p - A Novel Serum Biomarker of Testicular Germ Cell Tumors: Evidence for Specificity from Measurements in Testicular Vein Blood and in Neoplastic Hydrocele FluidKlaus-Peter Dieckmann, Meike Spiekermann, Thomas Balks, et al.
Journal of Cancer Research and Clinical Oncology|April 27, 2016
Testicular seminoma clinical stage 1: treatment outcome on a routine care levelKlaus-Peter Dieckmann, Inken Dralle-Filiz, Cord Matthies, et al.
BMC Urology|April 19, 2015
Testicular prostheses in patients with testicular cancer - acceptance rate and patient satisfactionKlaus-Peter Dieckmann, Petra Anheuser, Stefan Schmidt, et al.
Urologia Internationalis|April 20, 2016
Seminoma Clinical Stage 1 - Patterns of Care in GermanyKlaus-Peter Dieckmann, Inken Dralle-Filiz, Julia Heinzelbecker, et al.
Antibiotics (Basel, Switzerland)|July 29, 2023
Do or Don't: Results of a Multinational Survey on Antibiotic Prophylaxis in UrodynamicsFabian P Stangl, Laila Schneidewind, Florian M Wagenlehner, et al.
Central European Journal of Urology|November 3, 2018
Desperate need for better management of Fournier's gangreneJennifer Kranz, Daniel Schlager, Petra Anheuser, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 16, 2019
Serum Levels of MicroRNA-371a-3p (M371 Test) as a New Biomarker of Testicular Germ Cell Tumors: Results of a Prospective Multicentric StudyKlaus-Peter Dieckmann, Arlo Radtke, Lajos Geczi, et al.
Pageof 4